v3.26.1
FAIR VALUE MEASUREMENTS - Summary of Financial Instruments Measured at Fair Value on Recurring Basis (Details) - USD ($)
$ in Millions
Jun. 30, 2026
Dec. 31, 2025
Assets    
Foreign exchange contracts $ 1  
Available-for-sale debt securities 1 $ 1
Marketable equity securities 9 15
Total assets 11 16
Liabilities    
Foreign exchange contracts 3 1
Contingent payments related to acquisitions 10 7
Indemnifications related to kidney care separation 43 53
Total liabilities 56 61
Quoted prices in active markets for identical assets (Level 1)    
Assets    
Foreign exchange contracts 0  
Available-for-sale debt securities 0 0
Marketable equity securities 9 15
Total assets 9 15
Liabilities    
Foreign exchange contracts 0 0
Contingent payments related to acquisitions 0 0
Indemnifications related to kidney care separation 0 0
Total liabilities 0 0
Significant other observable inputs (Level 2)    
Assets    
Foreign exchange contracts 1  
Available-for-sale debt securities 0 0
Marketable equity securities 0 0
Total assets 1 0
Liabilities    
Foreign exchange contracts 3 1
Contingent payments related to acquisitions 0 0
Indemnifications related to kidney care separation 0 0
Total liabilities 3 1
Significant unobservable inputs (Level 3)    
Assets    
Foreign exchange contracts 0  
Available-for-sale debt securities 1 1
Marketable equity securities 0 0
Total assets 1 1
Liabilities    
Foreign exchange contracts 0 0
Contingent payments related to acquisitions 10 7
Indemnifications related to kidney care separation 43 53
Total liabilities $ 53 $ 60